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and Takayuki Shibamoto7Abstract
Background: Bjerkandera adusta (B. adusta) is one of the most important etiological fungi associated with chronic
cough. However, precise details of the inflammatory response to exposure are not well understood yet. B. adusta
was recently identified in Asian sand dust (ASD) aerosol. Therefore, in the present study the exacerbating effects of
ASD on B. adusta-induced lung inflammation and B. adusta + ASD on ovalbumin (OVA)-induced murine lung
eosinophilia were investigated using experimental mice.
Methods: In order to prepare testing samples, B. adusta obtained from ASD aerosol was inactivated by formalin
and ASD collected from the atmosphere was heated to remove toxic organic substances (H-ASD). CD-1 mice were
instilled intratracheally with 12 different samples prepared with various combinations of B. adusta, H-ASD, and OVA
in a normal saline solution. The lung pathology, cytological profiles in bronchoalveolar lavage fluid (BALF), and the
levels of inflammatory cytokines/chemokines in BALF were investigated.
Results: H-ASD aggravated the lung eosinophilia induced by B. adusta alone, which also aggravated the lung
eosinophilia induced by OVA. The mixture of OVA, H-ASD, and B. adusta caused serious fibrous thickening of the
subepithelial layer, eosinophil infiltration, and proliferation of goblet cells in the airways along with remarkable
increases of IL-13, eotaxin, IL-5, and MCP-3 in BALF.
Conclusions: The results of the present study demonstrated that B. adusta isolated from ASD aerosol induces
allergic lung diseases. H-ASD enhanced allergic reactions caused by OVA or B. adusta. A mixture of B. adusta,
H-ASD, and OVA caused the most remarkable exacerbation to the allergic airway inflammation via remarkable
increases of pro-inflammatory mediators.
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Bjerkandera adusta (B. adusta) is known to occur through-
out the world. This fungus produces abundant asexual
spores, so-called arthroconidia, from the hyphae [1]. The
asexual spores are known to be a fungal aeroallergen, which
causes an allergic fungal cough [2]. Therefore, this fungus is
one of the most significant etiological fungus-associated
chronic cough (FACC) [1]. However, it is not well under-
stood yet what type of inflammatory response is initiated in
the lungs of human with exposure to components in B.
adusta or infection caused by B. adusta.
Asian sand dust (ASD) storms arise from the dry and
semi-arid areas of southern Mongolia and Northeast
China. ASD is transported to East China, the Korean
Peninsula, and Japan. It even travels across the Pacific
Ocean to reach the United States [3,4]. Recently, B.
adusta was identified in ASD aerosol, which was col-
lected from the atmosphere in Suzu, Japan during the
occurrence of an Asian dust event [5]. Many patients
with FACC have been reported in Kanazawa (near Suzu
City) [1]. Above all, ASD events have been known to ex-
acerbate asthma for adults and children in Japan [6,7].
However, the role of ASD events in the occurrence of
these diseases (FACC, asthma) is not well understood
yet. It is crucial to investigate the effects of B. adusta
and ASD on airway diseases in order to find the relevant
treatment for patients of FACC or asthma.
In the present study, the exacerbating effects of ASD
on B. adusta-induced lung inflammation and fungus
and/or ASD on ovalbumin (OVA)-induced lung eosino-
philia were investigated using a mouse model of asthma.
Materials and methods
Animals
A total of 168 male CD-1 mice (5 weeks of age) were pur-
chased from Charles River Japan Inc. (Kanagawa, Japan).
The abnormal or unhealthy mice were removed after one
week and the remaining healthy mice were used at 6 weeks
of age. The mice were fed commercial diet CE-2 (CLEA
Japan Inc., Tokyo, Japan) and given water ad libitum. The
mice were housed in plastic cages lined with soft wood
chips. The cages were placed in a conventional room,
which was air conditioned at 23°C and 55–70% humidity
with a light/dark (12 h/12 h) cycle. CD-1 male mice were
used because of their moderate responsiveness to airway in-
flammation caused by OVA [8]. The present study adhered
to the U.S. National Institutes of Health guidelines for the
use of experimental animals. The animal care method was
approved by the Animal Care and Use Committee at Oita
University of Nursing and Health Sciences, Oita, Japan.
Preparation of particle samples
ASD was collected from the atmosphere using a high-
volume air sampler with a Teflon filter at the Universityof Occupational and Environmental Health, Kitakyushu,
Fukuoka, Japan during May 1st– 3nd, 2011 right after a
massive 3-day dust storm event occurred in East Asia.
The flow rate for collection was 770 L/min. The instru-
mental classification size (defined as the 50% cut-off size
of the aerodynamic diameter) was 5.9 μm in the 1st
stage, 2.8 μm in the 2nd stage, 1.7 μm in the 3rd stage,
0.91 μm in the 4th stage, and < 0.91 μm of back-up. The
size distribution peak of ASD was at 3.8 μm. The density
ranges of the ambient particulate matter measured by
LIDAR (Light Detection and Ranging) on May 1st - 3rd,
2011 were 350–550 μg/m3 in Nagasaki (Nagasaki Pre-
fectural Institute of Public Health and Environmental
Science), Japan.
The particle samples in a glass bottle were heated at
360°C for 30 min in an electric heater to remove toxic
materials (microbiological materials, sulfate, nitrate, etc.)
and labelled as H-ASD.
Fungus preparation
The aerosol samples—collected at 400 m above the ground
using a tethered balloon equipped with an aerosol sampler
on May 7, 2008 in Suzu, Ishikawa Prefecture—were inocu-
lated onto four culture agar plates (nutrient agar, blood
agar, potato dextrose agar, and Sabouraud dextrose agar).
After a few days of incubation, several microbial colonies
on the agar plates were transferred to new agar plates. A
total of 8 isolates were obtained. The 18S rRNA gene
(ca. 1650 bp) and the internal transcribed spacer (ITS)
region (ca. 620 bp) of the fungal isolate were sequenced
and compared with known sequences from the DDBJ
database. Sequences of the isolate were the most closely
related to B. adusta (similarities: > 99.9%). The fungal
isolate was also confirmed as B. adusta by microscopic
observation [5].
The density ranges of the asexual spore (4-5 μm size)
in the atmosphere of Suzu City during dust storm event
(May 1st -3rd, 2011) were about 1 million – 6 million
particles/m3, which were remarkably higher than the
general levels (about 5000 particles/m3) [9]. The asexual
spores may cause adverse effect to the health. Because B.
adusta produces asexual spores from the hyphae, the
fungal hyphae were used in this study.
The fungal hyphae cultivated were inactivated with 1%
formalin for 1 day at 4°C according to the vaccine manu-
facture method with slight modifications [10]. Briefly,
the inactivated B. adusta solution was centrifuged at
1200 rpm for 10 min. The resulting pellet was sus-
pended in a normal saline solution (Otsuka Co., Kyoto,
Japan) and then the suspension was sonicated for 1 min
with a UD-201 type ultrasonic disrupter with micro
tip (Tomy, Tokyo, Japan) under cooling conditions. The
suspension was centrifuged at 12,000 rpm for 10 min
5 times using a normal saline solution. The resulting
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dried under reduced pressure.
Analysis of LPS and β-glucan in H-ASD and B. adusta
The contents of LPS and β-glucan in H-ASD and B.
adusta were measured by a kinetic assay using Endospec
ES-24S set (Seikagaku Corp., Tokyo, Japan) for LPS ac-
tivity and Glucatell Kit (Associates of Cape Cod. Inc.,
MA, USA) for β-glucan activity. The experiments were
performed according to the manuals provided by the
manufacturers. Briefly, approximately 5 mg of H-ASD or
10 μg of B. adusta (dry weight) was suspended in 1 mL
water (LPS and β-glucan free; Seikagaku Corp., Tokyo,
Japan) and then allowed to stand at room temperature
for 2 h. LPS and β-glucan concentrations in the superna-
tants were determined using a Pyro Color-MP:Chromo-
genic Diazo-Coupling Kit (Associates of Cape Cod. Inc.,
MA, USA). The detection limits for LPS and β-glucan
were 0.001 EU/ml and 2 pg/ml, respectively.
Study protocol
Experimental mice were divided into twelve groups (n =
14 per group) and each group was treated with a specific
testing sample. The 12 testing samples (0.1 mL each of
0.9% NaCl normal saline solution) prepared for the
present study were control (containing normal saline
alone); H-ASD (0.1 mg H-ASD alone); B.ad 2 (2 μg B.
adusta alone); B.ad 8 (8 μg B. adusta alone); H-ASD +
B.ad 2 (0.1 mg H-ASD and 2 μg B. adusta); H-ASD + B.
ad 8 (0.1 mg H-ASD and 8 μg B. adusta); OVA alone
(1 μg); OVA +H-ASD (1 μg OVA and 0.1 mg H-ASD);
OVA + B.ad 2 (1 μg OVA and 2 μg B. adusta); OVA + B.
ad 8 (1 μg OVA and 8 μg B. adusta); OVA +H-ASD + B.
ad 2 (1 μg OVA, 0.1 mg H-ASD, and 2 μg B. adusta);
and OVA +H-ASD + B.ad 8 (1 μg OVA, 0.1 mg H-ASD,
and 8 μg B. adusta). One previous report indicated that
the microbe was present in ASD aerosol at approxi-
mately 10% [11]. The instillation dose of B. adust was
set at 2% (2 μg) and 8% (8 μg) for the one-time ASD in-
stillation dose (0.1 mg), because one kind of microbial
species was not considered to occupy 10% of total mi-
crobe in ASD aerosol. The one-time ASD instillation
dose (0.1 mg) was conducted according to a previously
reported method [12].
B. adusta, H-ASD, and OVA were suspended in a nor-
mal saline solution (Otsuka Co., Kyoto, Japan) and soni-
cated for 5 min with ultrasonic disrupter Model UD-201
with micro tip (Tomy, Tokyo, Japan) under cooling con-
ditions. A 0.1 mL saline solution containing the samples
described above was intratracheally instilled to the mice
through a polyethylene tube under anesthesia with 4%
halothane (Takeda Chemical, Osaka, Japan) four times at
2-week intervals. One day after the last administration,
the mice from all groups were killed by exsanguinationunder deep anesthesia by intraperitoneal injection of
pentobarbital.
The mice in each group (14 mice) were divided into
two sub-groups. The first (6 mice) was used for patho-
logical evaluation. The remaining 8 mice were used for
the analysis of cytokine and chemokine in the broncho-
alveolar lavage fluids (BALFs).
Pathological evaluation and BALF preparation
The lungs were fixed by a 10% neutral phosphate-buffered
formalin solution. After separation of the lobes, blocks
(2 mm thickness) were taken for paraffin embedding. The
embedded blocks were sectioned (3 μm thickness) and then
stained with periodic acid-schiff (PAS) to evaluate the de-
gree of proliferation of goblet cells in the bronchial epithe-
lium and thickening of the subepithelial layer in the main
bronchus. The sections were also stained with hematoxylin
and eosin (H & E) in order to evaluate the degree of infil-
tration of eosinophils or lymphocytes in the airway from
proximal to distal [12,13].
A pathological analysis of the inflammatory cells and epi-
thelial cells in the airways of each lung lobe on the slides
was performed using a Nikon ECLIPSE light microscope
(Nikon Co., Tokyo, Japan). The degree of proliferation of
goblet cells in the bronchial epithelium was graded on the
following scale: 0, not present; 1, slight; 2, mild; 3, moder-
ate; 4, moderate to marked; and 5, marked. ‘Slight’ was
defined as less than 20% of the airway having goblet cells
stained with PAS; ‘mild’ as 21 –4 0%; ‘moderate’ as 41 –
60%; ‘moderate to marked’ as 61–80%; and ‘marked’ as
more than 81% [12,13]. The degree of thickening of the
subepithelial layer in the main bronchus was graded on the
following scale: 0, not present; 1, slight; 2, mild; 3, moder-
ate; 4, moderate to marked; and 5, marked. ‘Slight’ was de-
fined as 5–12 μm of the main bronchus with fibroblasts
stained with PAS; ‘mild’ as 13–20 μm; ‘moderate’ as 21–
28 μm; ‘moderate to marked’ as 29-36 μm; and ‘marked’ as
more than 37 μm [13].
Pathological changes were assessed on one slide stained
with PAS per mouse. This evaluation procedure was
performed by two pathologists who cross-checked the
data with blinded specimens. The values were mean ±
SE (n = 6).
BALF preparation and cell counts were conducted ac-
cording to a previously reported method [12,13]. The total
amount of the lavages collected from individual mice was
measured for the protein levels of cytokines and chemo-
kines in BALF. The total cell counts of each fresh fluid spe-
cimen were determined using a hemocytometer.
Quantitation of cytokines and chemokines in BALFs
The cytokine protein levels in the BALF were deter-
mined using ELISA. IL-5 and IL-12 were measured
using an ELISA kit from Thermo Scientific (Rockford,
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Bioscience (San Diego, CA, USA). KC, MCP-1, MIP-1α,
RANTES, TNF-α, Eotaxin, IFN-γ, TGF-β1, IL-1β, IL-4,
IL-6, IL-10, IL-13, and IL-33 were measured with an
ELISA kit from R&D Systems (Minneapolis, MN). These
cytokines and chemokines were measured by individual
ELISA kit.Measurement of antigen-specific IgG1 and IgE antibodies
OVA-specific immunoglobulin E (IgE) and IgG1 antibodies
were measured using a Mouse OVA-IgE ELISA kit and a
Mouse OVA-IgG1 ELISA kit (Shibayagi, Shibukawa, Japan).
The absorption at 450 nm (sub-wavelength, 620 nm) for
OVA-specific IgE and IgG1 antibody was measured using a
microplate reader (Spectrafluor; Tecan, Salzburg, Austria).Statistical analysis
Statistical analyses of the pathologic evaluations of the
airway, cytokine and chemokine proteins in BALF were
conducted using the Tukey Test for Pairwise Compari-
sons (KyPlot Ver.5, Kyens Lab Inc., Tokyo, Japan). Dif-
ferences among groups were determined as statistically
significant at a level of p < 0.05.Figure 1 Cellular profile in bronchoalveolarlavage fluids (BALF). All va
‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05 vs. H-ASD + B.ad 2; §p < 0
δp < 0.05 vs. OVA + B.ad 2; ψp < 0.05 vs. OVA + B.ad 8.Results
Contents of LPS and β-glucan in H-ASD and B. adusta
LPS and β-glucan were not detected in the H-ASD samples.
The β-glucan content in B. adusta was 32.8 ng/mg. LPS
was not detected in B. adusta.
Enhancement of cell numbers in BALF by B. adusta
and H-ASD
Figure 1 shows the numbers of macrophages, neutro-
phils, eosinophils, and lymphocytes determined in BALF
from the control and treated groups. The significant in-
crease of these BAL cells was resulted by B.ad 8 alone,
H-ASD + B.ad 2/B.ad 8, OVA+B.ad 2/B.ad 8, and OVA+
H-ASD+B.ad 2/B.ad 8. Numbers of BAL cells, especially
neutrophils and eosinophils of all substances increased dose
relatively by B. adusta. In particular, significant effects by
the addition of B.ad 8 were observed in neutrophils and eo-
sinophils. Overall, H-ASD played an important role in the
enhancement of inflammatory cells in BALF.
On the other hand, OVA+H-ASD +B.ad 2 and OVA+
H-ASD+B.ad 8 significantly decreased eosinophil numbers
compared with H-ASD+ B.ad 2 and H-ASD+B.ad 8, sug-
gesting that OVA inhibits the action of B. adusta toward
eosinophil in BALF.lues expressed as mean ± SE. *p < 0.05 vs. Control; †P < 0.05 vs. B.ad 2;
.05 vs. H-ASD + B.ad 8; &p < 0.05 vs. OVA; £p < 0.05 vs. OVA + H-ASD;
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H-ASD and B. adusta
Figure 2 shows the pathological changes caused by the
particle samples in the murine airway. Figures 3 (PAS
stain) and 4 (HE stain) show the effects of H-ASD and
B. adusta on pathological changes in the lungs. No
pathologic alteration was observed in the lungs of the
control (A in Figures 3 and 4). Effects by particle sam-
ples exhibited results similar to the case of cell numbers
in BALF. Exposure to B.ad 8 alone (B in Figure 3) re-
sulted in a significant increase in proliferation of goblet
cells, infiltration of eosinophils, and lymphocytes in the
submucosa of the airway compared with the control
(refer to Figure 2), and caused fibrous thickening of the
subepithelial layer in the airway (B in Figure 3). H-ASD
alone (C in Figures 3 and 4) or OVA alone (E in
Figures 3 and 4) caused only slight proliferation of bron-
chial cells and infiltration of macrophages in the alveoli
but no change of infiltration of eosinophils.
When B.ad 2 or B.ad 8 was mixed with H-ASD, prolif-
eration of goblet cells in the airway epithelium and
infiltration of eosinophils and lymphocytes in the sub-
mucosa of the airway and fibrous thickening of theFigure 2 Evaluation of pathological changes in the murine airway. Th
none; (1) slight; (2) mild; (3) moderate; (4) moderate to marked; (5) marked
were conducted using Tukey for Pairwise Comparisons. *p < 0.05 vs. Contro
vs. OVA; §p < 0.05 vs. OVA + H-ASD.subepithelial layer in the airway were observed (D in
Figures 3 and 4). These pathological changes in the H-
ASD + B.ad 8 group were greater than in the H-ASD +
B.ad 2 group (Figure 2).
When B.ad 2 was added to OVA, mild proliferation of
goblet cells in the airway epithelium and infiltration of
eosinophil and lymphocytes in the submucosa along
with mild fibrous thickening of the subepithelial layer in
the airway were recognized. A further increase of these
pathological changes (F in Figures 3 and 4) was observed
by the addition of B.ad 8 compared with OVA + B.ad 2.
These changes were significant compared with the con-
trol and OVA alone (Figure 2).
OVA +H-ASD caused mild pathological alterations
(G in Figures 3 and 4), whereas the addition of B.ad 2
increased pathological changes such as mild to moderate
goblet cell proliferation, eosinophil infiltration, and accu-
mulation of lymphocyte in the submucosa of airway
compared with the control, B.ad 2, H-ASD, and OVA.
As shown in Figure 2, the addition of B.ad 8 caused the
greatest increase of four items in pathological changes
(H in Figures 3 and 4) compared with the control and
promoted a serious fibrous thickening in the airwaye degree of pathological changes in the airway was estimated as: (0)
. All values were expressed as mean ± SE (n = 6). Statistical analyses
l; †P < 0.05 vs. B.ad 2; ‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05
Figure 3 Effects of testing samples on pathological changes in the lungs. No pathologic alterations were seen in the lungs of the control
(A). Mild proliferation of goblet cells that have mucus stained pink with PAS in airway epithelium and moderate fibrous thickening of the
subepithelial layer in the airway exposed to B.ad 8 alone (B). Very slight proliferation of bronchial cells exposed to H-ASD alone (C). Mild
proliferation of goblet cells that have mucus stained pink with PAS in the airway epithelium and infiltration of inflammatory cells in the
submucosa of airway and mild fibrous thickening of the subepithelial layer in the airway exposed to H-ASD + B.ad 8 (D). Very slight proliferation
of goblet cells in the airway epithelium and slight infiltration of inflammatory cells in the submucosa of airway exposed to OVA alone (E). Mild to
moderate proliferation of goblet cells in the airway epithelium and infiltration of inflammatory cells in the submucosa of airway along with mild
fibrous thickening of the subepithelial layer in the airway exposed to OVA + B.ad 8 (F). Slight goblet cell proliferation and slight infiltration of
inflammatory cells in the submucosa of airway exposed to OVA + H-ASD (G). Moderate goblet cell proliferation, numerous inflammatory cells in
the submucosa of airway, and serious fibrous thickening of the subepithelial layer in the airway and macrophages scattered in alveoli exposed to
OVA + H-ASD + B.ad 8 (H). (A–H) PAS stain; bar = 100 μm.
Figure 4 Effects of B. adusta on infiltration of inflammatory cells in the airway. No pathologic changes in the lungs of the control (A).
Slight infiltration of eosinophils and lymphocyte in the submucosa of airway exposed to B.ad 8 alone (B). No pathologic changes in the airway
and in the alveoli exposed to H-ASD alone (C) H-ASD + B.ad 2 caused mild accumulation of lymphocytes in the submucosa of airway (C). Mild to
moderate eosinophils, neutrophils and lymphocytes in the submucosa of airway exposed to H-ASD + B.ad 8 (D). Very slight infiltration of
eosinophil and lymphocytes in the submucosa in the airway (E). Mild to moderate infiltration of eosinophils, neutrophils and lymphocytes in
the submucosa of airway exposed to OVA + B.ad 8 (F). Mild infiltration of eosinophils, neutrophils and lymphocytes in the submucosa of airway
exposed to OVA+H-ASD (G). Marked infiltration of eosinophils, neutrophils and lymphocytes in the submucosa of airway exposed to OVA+H-ASD +
B.ad 8 (H). (A–H) HE stain; bar = 50 μm.
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role in the enhancement of pathological changes.
Enhancement of cytokines and chemokines in BALF by
particle samples
The protein levels of cytokines and chemokines deter-
mined in BALF are shown in Figures 5, 6, 7 and 8. As
shown in Figure 5, B. adusta increased all proteins, in
particular KC, determined in BALF with a dose relation.
The mixture of H-ASD and B. adusta increased all pro-
teins significantly. In particular, IL-12 increased 7-fold
with the addition of B.ad 8 to H-ASD. A considerable
increase of RANTES was also observed in this sample.
In the case of the OVA treated groups, the addition of B.
adusta also promoted an increase of these proteins, in
particular KC. When B.ad 8 was added to an OVA +H-
ASD sample, IL-12 and MCP-1 increased remarkably
compared with samples treated with OVA alone. On the
other hand, addition of OVA to H-ASD + B. adusta sam-
ple decreased IL-12, MCP-1 and RANTES, suggesting
that OVA inhibits their activity.
Figure 6 shows the expression of IL-1β, IL-6, TNF-α,
and MIP-1α in BALF. OVA alone did not exhibit any ap-
preciable activity. H-ASD showed moderate effects of an
increase of proteins, of which MIP-1α was the most af-
fected. An increase of MIP-1α was also observed in theFigure 5 Expressions of IL-12, KC, MCP-1 and RANTES in BALF. All valu
vs. B.ad 2; ‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05 vs. OVA; §p < 0.case of OVA +H-ASD. Obvious increases of all proteins
with a dose relation were obtained by the presence of B.
adusta. It is obvious that B. adusta plays an important
role in the increase of these proteins. In particular, B.ad
8 alone clearly increased IL-1β and TNF-α compared
with the control group. Overall, the addition of B. adu-
sta to H-ASD and OVA samples increased proteins
markedly. Generally, the presence of OVA decreased
proteins. For example, the addition of OVA to H-ASD
removed TNF-α completely.
Figure 7 shows the expression of IL-5, IL-13, Eotaxin,
and MCP-3 in BALF. Only trace levels of MCP-3 were
detected in the control groups. H-ASD and OVA alone
did not increase any proteins analyzed in BALF. B. adu-
sta alone increased levels of proteins slightly. On the
other hand, a mixture of H-ASD or OVA with B. adusta
clearly increased the levels of proteins. H-ASD + B.ad 8
notably increased IL-13 and Eotaxin compared with the
control and H-ASD alone. In the OVA treated groups,
OVA + B.ad 8 considerably increased IL-5 compared to
the control and OVA-only groups. OVA +H-ASD + B.
adusta markedly increased all proteins with a dose rela-
tion compared with all other samples.
Figure 8 shows the expression of TGF-β1 and IL-10 in
BALF. No proteins were detected in the samples from
control, B. adusta alone, OVA alone, and OVA +H-es were expressed as mean ± SE (n = 8). *p < 0.05 vs. Control; †P < 0.05
05 vs. OVA + H-ASD; &p < 0.05 vs. H-ASD + B.ad 8.
Figure 6 Expressions of IL-1β, IL-6, TNF-α and MIP-1α in BALF. All values were expressed as mean ± SE (n = 8). *p < 0.05 vs. Control; †P < 0.05
vs. B.ad 2; ‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05 vs. OVA; §p < 0.05 vs. OVA + H-ASD; &p < 0.05 vs. OVA + B.ad 8.
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the BALF from the groups treated with mixtures of H-
ASD and B.ad 8. In the OVA treated groups, the
addition of B.ad 8 increased TGF-β1 and IL-10 moder-
ately compared with the groups treated with OVA alone.
OVA +H-ASD + B. adusta markedly increased TGF-β1
with a dose relation compared with all other samples.
The significant increase of IFN-γ, IL-4 and IL-33 was
not detected in this study.
Figure 9 shows the expression of OVA-specific IgG1
in serum. OVA +H-ASD + B.ad 2/B.ad 8 increased
IgG1 compared with OVA alone. However, no induc-
tion of OVA-specific IgE was observed in any of these
groups.
Discussion
It is known that ASD aerosol contains many kinds of mi-
croorganisms [5,14]. B. adusta, isolated from the wind-
borne ASD aerosol, may affect FACC or asthmatic patients
negatively. In the present study, the exacerbating effects of
ASD on B. adusta-induced lung inflammation and the ex-
acerbating effects of the fungus and ASD on ovalbumin
(OVA)-induced lung eosinophilia in a mouse model of
asthma were examined. B. adusta is a mushroom fungus
that grows in fields and colonizes rotting wood. The fungus,white-rot fungus, secretes multiple lignin peroxidase iso-
zymes [15,16] and has been applied for the biodegradation
of polycyclic aromatic hydrocarbons [17], synthetic dyes
[18], and synthetic polymer nylon [19] in agricultural fields.
This study demonstrated that the formalin-inactivated
fungus causes lung eosinophilia in mice. The inactivated
B. adusta alone dose relatively increased neutrophils and
eosinophils along with proinflammatory mediators MIP-
1α, KC and TNF-α in BALF. Pathologically, the fungus
caused eosinophil recruitment in the submucosa of the
airway along with proliferation of goblet cells in the
bronchial epithelium, suggesting that it acts as an anti-
gen for human asthma. The treatment of inactivated
B.adusta with H-ASD caused further increases in in-
flammatory cell numbers, pro-inflammatory cytokines
(IL-1β, IL-5, IL-6, IL-12, IL-13), and chemokines
(Eotaxin, RANTES, MIP-1α, KC, MPC-1, MCP-3) in
BALF. The pathological changes in the airway induced
by the co-treatment were more remarkable than B.
adusta treatment alone, suggesting that H-ASD en-
hances B.adusta-induced lung eosinophilia via remark-
able increases of these pro-inflammatory mediators,
especially eosinophil-relevant chemokine MCP-3, cyto-
kine IL-5 and Th2-mediated cytokine IL-13. Eosino-
phils are reportedly implicated in tissue destruction in
Figure 7 Expressions of IL-5, IL-13, Eotaxin and MCP-3 in BALF. All values were expressed as mean ± SE (n = 8). *p < 0.05 vs. Control; †P < 0.05
vs. B.ad 2; ‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05 vs. OVA; §p < 0.05 vs. OVA + H-ASD; &p < 0.05 vs. OVA + B.ad 8.
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proteins cause bronchial mucosal damage in asthmatic
airways, they may exacerbate the symptoms of asthma
[21]. IL-13 has been shown to stimulate B cells and
subsequently produce antigen specific antibodies [22].
It also promotes mucous secretion and the productionFigure 8 Expressions of TGF-β1 and IL-10 in BALF. All values were expr
‡p < 0.05 vs. B.ad 8; ¶p < 0.05 vs. H-ASD; #p < 0.05 vs. H-ASD + B.ad 2; §p < 0
δp < 0.05 vs. OVA + B.ad 2; ψp < 0.05 vs. OVA + B.ad 8.of mucous cells, such as goblet cells, in the bronchial
epithelium [23]. Therefore, the airway injury resulting
from co-treatment may be due to enhancement of eo-
sinophilic airway-inflammation.
The pathway related to NF-κB activation by β-glucan
reportedly indicated an association between TLR2 andessed as mean ± SE (n = 8). *p < 0.05 vs. Control; †P < 0.05 vs. B.ad 2;
.05 vs. H-ASD + B.ad 8; &p < 0.05 vs. OVA; £p < 0.05 vs. OVA + H-ASD;
Figure 9 Effects of testing samples on IgG1 production in serum. According to the manufacturer’s protocol, 1 U of the anti-OVA IgG1 is
defined as 160 ng of the antibody. All values were expressed as mean ± SE. *p < 0.05 vs. Control; †p < 0.05 vs. B.ad 2; ‡p < 0.05 vs. B.ad 8; ¶p < 0.05
vs. H-ASD; #p < 0.05 vs. H-ASD + B.ad 2; §p < 0.05 vs. H-ASD + B.ad 8; &p < 0.01 vs. OVA.
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(32.8 ng/mg) in B. adusta was detected using a kinetic
assay in the present study. Therefore, it is proposed that
the aggravation by H-ASD is due to the activation of
TLR2-Dectin1-NF-κB signaling pathway that subse-
quently causes the production of inflammatory cyto-
kines. However, the present study does not provide
sufficient evidence to determine the role of β-glucan in
allergic reactions.
In the case of the OVA treated groups, the addition of
B. adusta increased eosinophil numbers along with their
relevant cytokines and chemokines (Figure 7). Similar
results were observed for neutrophil numbers and their
relevant pro-inflammatory mediators (Figure 5). The
asthma-like alterations induced in the airway by B. adu-
sta with OVA were much higher than by treatment with
B. adusta alone. Previous reports have demonstrated
that co-treatment of TLR2-ligand Pam3Cys and OVA
activates an OVA-associated Th2-biased immune re-
sponse in experimental asthma [25]. These results
suggest that B. adusta with β-glucan activates an OVA-
related Th2-biased immune response through TLR2-
dependent signaling pathways. The addition of H-ASD
also enhanced Th2-biased immune response in the
present study. The results are consistent with a previous
study [14]. When mice were treated with OVA+H-ASD+
B. adusta, serious fibrous thickening of the subepithe-
lial layer, eosinophil infiltration, and proliferation of
goblet cells in the airway along with remarkable in-
creases of Th2 cytokine IL-13 and eosinophil relevant
cytokines and chemokines induced in BALF were observed(Figure 7). Thus, allergen-induced asthma-like features
must be more aggravated by H-ASD+B. adusta.
Addition of OVA to a particle sample consisting of H-
ASD and B. adusta increased TGF-β (Figure 8). TGF-β1
is well known to possess various biological activities in-
cluding immunosuppression [26]. However, the suppres-
sive effects on the Th2 response as result of an increase
of TGF-β was not detected in this study.
In addition, TGF-β1 is also well known as a repair and
profibrotic cytokine [27]. Hyperplasia of bronchial struc-
tural cells, like fibroblasts and smooth muscle cells in
the airway, is a typical feature of airway remodeling. The
induction levels of TGF-β1 in the present study paral-
leled the severity of fibrous thickening of the subepithe-
lial layer in the airway. Therefore, TGF-β1 may play an
important role in the development of serious fibrous
thickening (airway remodeling) in this experimental
asthma, especially in the OVA +H-ASD + B.ad 8 treated
groups.
IL-10 produced by Treg cells or Type 1 regulatory T
(Tr1) cells also suppresses the Th2 cell-driven response
to allergens, as does TGF-β1 [28,29]. However, the sup-
pressive effect to Th2 response by an increase of IL-10
in the OVA + B.ad 8 and OVA +H-ASD + B.ad 8 treated
groups was not detected.
In the present study, an adjuvant effect of B. adusta
and H-ASD toward OVA-specific IgG1 production was
detected but OVA-specific IgE production was not
(Figure 9). Antigen-specific IgG1 can cause degranulation
via an Fcg RII receptor on the eosinophil’s surface [30].
Therefore, antibodies may play an important role in
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http://www.aacijournal.com/content/10/1/10the aggravation of lung eosinophilia caused by OVA+H-
ASD + B.ad.
Conclusions
B. adusta isolated from ASD aerosol caused murine lung
eosinophilia and heat-treated ASD (H-ASD) aggravated
the lung eosinophilia associated with B. adusta. B. adu-
sta aggravated OVA-induced lung eosinophilia. A mix-
ture of B. adusta, H-ASD, and OVA caused the most
remarkable exacerbation to the allergic airway inflamma-
tion in experimental animals. Therefore, the present
study indicates that B. adusta is an allergic exacerbating
factor and acts as an inducer of eosinophilic lung disease
and that H-ASD is an allergic exacerbating factor.
The adverse effects of dust containing minerals and
biogenic agents on human respiratory diseases have
become a public concern. In particular, atmospheric ex-
posure to fungi, bacteria, and silica-carrying particulate
matters may affect human health directly through aller-
gic induction of respiratory stress. Therefore, the results
obtained in the present study may serve as a warning
about the ill effects of airborne sand dust on the human
respiratory system and also be useful in finding the ap-
propriate method for treating patients with FACC or
asthma. In order to clarify an association of ASD events
with the exacerbation of FACC or asthma, epidemio-
logical study is in order.
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